Comments
Loading...
Rein Therapeutics (NASDAQ:RNTX) Stock, Earnings Estimates, EPS, And Revenue
Rein Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 14
EPS Estimate
$-0.480
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Rein Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Rein Therapeutics (RNTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.27 | $-0.41 | 34.2 % |
| Q2 | 2024-08-14 | $-0.45 | $-0.42 | -7.14 % |
| Q1 | 2023-05-08 | $-1.05 | $-0.86 | -22.1 % |
| Q4 | 2023-03-20 | $-1.02 | $-1.36 | 25.0 % |
Rein Therapeutics (RNTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Rein Therapeutics (NASDAQ:RNTX) reporting earnings?
Rein Therapeutics (RNTX) is scheduled to report earnings on April 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Rein Therapeutics (NASDAQ:RNTX)?
The Actual EPS was $-0.27, which beat the estimate of $-0.41.
What were Rein Therapeutics’s (NASDAQ:RNTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.